Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Eligibility rules for Roth IRAs in 2026 determine who can contribute based on income and filing status, guiding your retirement planning.
15,780 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Micron’s stock is dropping amid questions about whether Google's new AI memory efficiency could curb DRAM demand. Her...
A family dispute highlights how large gifts to minors intersect with tax rules, saving goals, and the long arc of a y...
If you’re a retiree with AI stock exposure, you’re not alone. This guide explains how to protect income, rebalance ri...
A year after welcoming her fourth daughter, Kylie Kelce speaks out against the pressure to 'bounce back' quickly. Thi...
Paris tightens rules on short-term rentals, signaling a broader European crackdown on illegal Airbnb listings. Offici...
Lean In is undergoing a major overhaul, including a 25% staff reduction and a new CEO, as it pivots to engage with tr...
Energy Holdings disclosed a large stake in Tecnoglass, prompting questions about what tecnoglass stock after energy s...
Multicoin Capital disclosed a substantial Zcash position, triggering a double-digit rally in ZEC. The move underscore...
Strategy, led by Michael Saylor, plans to fund STRC dividends by selling Bitcoin, with a long-term goal to buy more B...
Shopify delivered strong quarterly results, but the stock traded lower as guidance softened. This article explains wh...
A global pop icon choosing to age naturally isn’t just about looks. This article translates that stance into money le...